Etomidate infusion at low doses is an effective and safe treatment for severe Cushing’s syndrome outside intensive care

in European Journal of Endocrinology
View More View Less
  • 1 Endocrinology Department, Cliniques Universitaires Saint Luc, Brussels, Belgium
  • 2 Endocrinology Department, Cliniques Universitaires de Bruxelles Hôpital Erasme, Bruxelles, Belgium
  • 3 Endocrinology Department, Cliniques Saint Pierre, Ottignies, Belgium

Correspondence should be addressed to D Maiter; Email: dominique.maiter@uclouvain.be

The authors of the aforementioned article published in this journal (vol 183 Iss 2 pages: 161–167) apologise for errors in reporting the dosage of etomidate in several places in their article.

The corrections are listed below:

In the Methods section of the Abstract, the correct line should read as follows and not as published:

Methods

We compared data from patients with severe CS treated with high starting doses of etomidate (median: 0.30 mg/kg BW/h) in ICU or with lower starting doses (median: 0.025 mg/kg BW/h) in non-ICU medical wards.

In the main article, Methods section, third paragraph, the following line should read as follows and not as published:

Another patient (patient # 14, Supplementary Table 1) was first treated in ICU with a high starting dose (0.30 mg/kg/h) for 1 day, then etomidate infusion was decreased to low doses (0.04 mg/kg/h) in order to maintain cortisol levels in the target range.

In the legend to Table 2, the explanation for the asterisk should read as follows and not as published:

*One patient in the high-dose group was first treated in ICU with a high starting dose (0.30 mg/kg/h) for 1 day, then the dose was reduced to 0.04 mg/kg/h in order to maintain cortisol levels in the target range.

The authors apologise for any inconvenience or confusion caused by these errors.

If the inline PDF is not rendering correctly, you can download the PDF file here.

 

     European Society of Endocrinology

Sept 2018 onwards Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 147 147 39
PDF Downloads 46 46 8